ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

ONS Scientific Program Grows

June 20, 1980